- Home
- EGP vs RGEN Comparison
EGP vs RGEN Comparison
Compare EGP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGP
- RGEN
- Stock Information
- Founded
- EGP 1969
- RGEN 1981
- Country
- EGP United States
- RGEN United States
- Employees
- EGP N/A
- RGEN N/A
- Industry
- EGP Real Estate Investment Trusts
- RGEN Medical/Dental Instruments
- Sector
- EGP Real Estate
- RGEN Health Care
- Exchange
- EGP Nasdaq
- RGEN Nasdaq
- Market Cap
- EGP 8.9B
- RGEN 8.2B
- IPO Year
- EGP N/A
- RGEN N/A
- Fundamental
- Price
- EGP $187.04
- RGEN $141.78
- Analyst Decision
- EGP Buy
- RGEN Buy
- Analyst Count
- EGP 14
- RGEN 10
- Target Price
- EGP $192.93
- RGEN $188.38
- AVG Volume (30 Days)
- EGP 275.5K
- RGEN 926.2K
- Earning Date
- EGP 10-22-2024
- RGEN 10-29-2024
- Dividend Yield
- EGP 3.04%
- RGEN N/A
- EPS Growth
- EGP 27.73
- RGEN N/A
- EPS
- EGP 4.79
- RGEN N/A
- Revenue
- EGP $608,993,000.00
- RGEN $602,354,000.00
- Revenue This Year
- EGP N/A
- RGEN $0.08
- Revenue Next Year
- EGP $9.93
- RGEN $12.97
- P/E Ratio
- EGP $38.46
- RGEN N/A
- Revenue Growth
- EGP 14.82
- RGEN N/A
- 52 Week Low
- EGP $154.75
- RGEN $110.45
- 52 Week High
- EGP $192.61
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- EGP 51.44
- RGEN 43.50
- Support Level
- EGP $180.92
- RGEN $138.80
- Resistance Level
- EGP $187.41
- RGEN $150.72
- Average True Range (ATR)
- EGP 2.94
- RGEN 4.98
- MACD
- EGP -0.30
- RGEN -0.92
- Stochastic Oscillator
- EGP 45.90
- RGEN 24.50
About EGP EastGroup Properties Inc.
EastGroup Properties Inc is an equity real estate investment trust. It is engaged in the development, acquisition, and operation of industrial properties in Sunbelt markets throughout the United States, predominantly in the states of Florida, Texas, Arizona, California, and North Carolina. The company manages a portfolio of industrial properties. The vast majority of these properties are multi-tenant business distribution buildings that provide large warehousing and office space for customers. The company derives its revenue in the form of rental income.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.